Showing results (361-370 of 700) with videos related to
Sort By:
Pageof 70
American Journal of Hematology|March 5, 2020
Utilizing multiparametric flow cytometry in the diagnosis of patients with primary plasma cell leukemiaLaura A Evans, Dragan Jevremovic, Bharat Nandakumar, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 27, 2021
Kidney Transplantation in Patients With Monoclonal Gammopathy of Renal Significance (MGRS)-Associated Lesions: A Case SeriesCihan Heybeli, Mariam Priya Alexander, Andrew J Bentall, et al.Blood Cancer Journal|December 14, 2020
Correlation between urine ACR and 24-h proteinuria in a real-world cohort of systemic AL amyloidosis patientsAlissa Visram, Abdullah S Al Saleh, Harsh Parmar, et al.American Journal of Hematology|October 28, 2021
Prognostic significance of acquired 1q22 gain in multiple myelomaHadiyah Y Audil, Joselle M Cook, Patricia T Greipp, et al.Blood Advances|July 27, 2026
Predictors of post-transplant measurable residual disease negativity and impact on clinical outcomes in multiple myelomaAbiola Bolarinwa, Saurabh S Zanwar, Nadine Abdallah, et al.Mayo Clinic Proceedings|July 17, 2010
Idiopathic systemic capillary leak syndrome (Clarkson's disease): the Mayo clinic experiencePrashant Kapoor, Patricia T Greipp, Eric W Schaefer, et al.British Journal of Haematology|March 6, 2008
Outcome after autologous stem cell transplantation for multiple myeloma in patients with preceding plasma cell disordersShaji K Kumar, David Dingli, Martha Q Lacy, et al.Haematologica|March 9, 2019
Histone deacetylase inhibition in combination with MEK or BCL-2 inhibition in multiple myelomaVijay G Ramakrishnan, Kevin C Miller, Elaine P Macon, et al.American Journal of Hematology|April 23, 2008
Autologous stem cell transplantation in patients of 70 years and older with multiple myeloma: Results from a matched pair analysisShaji K Kumar, David Dingli, Martha Q Lacy, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2012
Polyclonal immunoglobulin free light chain levels predict survival in myeloid neoplasmsAnimesh Pardanani, Terra L Lasho, Christy M Finke, et al.Pageof 70